Indication

Group B Streptococcus pelvic inflammatory disease

Group B Streptococcus pelvic inflammatory disease is an upper female genital tract infection caused by the ascending spread of *Streptococcus agalactiae* (Group B Streptococcus) from the lower reproductive tract. Read more about Group B Streptococcus pelvic inflammatory disease

13 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common Group B Streptococcus pelvic inflammatory disease therapies.

Showing 1–9 of 13 drugs

Filter & compare in the drug finder →Opens the drug finder with Group B Streptococcus pelvic inflammatory disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Group B Streptococcus pelvic inflammatory disease.

Group B Streptococcus pelvic inflammatory disease is an upper female genital tract infection caused by the ascending spread of *Streptococcus agalactiae* (Group B Streptococcus) from the lower reproductive tract.

Primarily affecting women of reproductive age, this clinical state encompasses inflammation involving the endometrium, fallopian tubes, ovaries, or adjacent pelvic structures.

Pathophysiologically, the organism disrupts mucosal defenses to induce acute local tissue inflammation, which can progress to endometritis, salpingitis, pelvic peritonitis, or tubo-ovarian abscesses.

Typical clinical features include lower abdominal and pelvic pain, cervical motion tenderness, uterine or adnexal tenderness, purulent cervical discharge, and systemic manifestations such as fever.

Personalize your experience

Follow Group B Streptococcus pelvic inflammatory disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it